Patents by Inventor Keiko HISA

Keiko HISA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10792302
    Abstract: The present invention provides a prophylactic or therapeutic composition for a metabolic disorder, a composition for amplifying the amount of short-chain fatty acid in the intestine, or a composition for decreasing a ratio of bacteria belonging to the Firmicutes to bacteria belonging to the Bacteroidetes in the intestine, each containing an exopolysaccharide produced by Leuconostoc mesenteroides, and further, a food, a pharmaceutical product, a feed and the like containing the composition.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: October 6, 2020
    Assignee: Noster Inc.
    Inventors: Ikuo Kimura, Kenji Yamamoto, Keiko Hisa
  • Patent number: 10507222
    Abstract: The present invention provides a lactobacillus that improves hyperuricemia, fatty liver and a lifestyle-related disease, and a composition containing the lactobacillus.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: December 17, 2019
    Assignee: NITTO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Yasunori Yonejima, Keiko Hisa, Yoshie Uchibori
  • Publication number: 20190223464
    Abstract: The present invention provides lactic acid bacterium-containing chocolate containing a lactic acid bacterium in a living state, wherein the average particle size of the solid particles in the lactic acid bacterium-containing chocolate is larger than 1 ?m and less than 9 ?m, and a manufacturing method thereof.
    Type: Application
    Filed: August 10, 2017
    Publication date: July 25, 2019
    Applicants: NITTO PHARMACEUTICAL INDUSTRIES, LTD., LOTTE CO., LTD.
    Inventors: Hiroaki ASHITANI, Toshiyuki KOYAMA, Yoko USAMIKRANK, Yusuke KABUKI, Yasunori YONEJIMA, Keiko HISA
  • Publication number: 20190099438
    Abstract: The present invention provides a prophylactic or therapeutic composition for a metabolic disorder, a composition for amplifying the amount of short-chain fatty acid in the intestine, or a composition for decreasing a ratio of bacteria belonging to the Firmicutes to bacteria belonging to the Bacteroidetes in the intestine, each containing an exopolysaccharide produced by Leuconostoc mesenteroides, and further, a food, a pharmaceutical product, a feed and the like containing the composition.
    Type: Application
    Filed: February 24, 2017
    Publication date: April 4, 2019
    Applicant: NITTO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Ikuo KIMURA, Kenji YAMAMOTO, Keiko HISA
  • Patent number: 10093749
    Abstract: Provided are exopolysaccharide produced by novel lactic acid bacteria having an IgA production promoting ability, a production method of the exopolysaccharide, a composition containing the exopolysaccharide, and the like.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: October 9, 2018
    Assignee: NITTO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Kenji Yamamoto, Chiaki Matsuzaki, Keiko Hisa
  • Publication number: 20180206540
    Abstract: By adding a viable lactic acid bacterium to a fat or oil composition, the present invention has succeeded in producing a lactic acid bacterium-containing fat or oil composition that has a high viability of the lactic acid bacterium and an excellent resistance to acids. By adding lactic acid bacteria powder or a chocolate with a high lactic acid bacterium concentration to a chocolate dough after tempering and before molding, moreover, the present invention has succeeded in producing a lactic acid bacterium-containing chocolate including a viable lactic acid bacterium by a simple producing method. Thus, provided is a lactic acid bacterium-containing chocolate with high palatability that contains a viable lactic acid bacterium.
    Type: Application
    Filed: May 31, 2016
    Publication date: July 26, 2018
    Inventors: Hiroaki ASHITANI, Toshiyuki KOYAMA, Yoko USAMIKRANK, Tomokazu ISHIZUKA, Keiji TADOKORO, Yusuke KABUKI, Yasunori YONEJIMA, Keiko HISA
  • Publication number: 20170202890
    Abstract: The present invention provides a lactobacillus that improves hyperuricemia, fatty liver and a lifestyle-related disease, and a composition containing the lactobacillus.
    Type: Application
    Filed: May 28, 2015
    Publication date: July 20, 2017
    Applicant: NITTO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Yasunori YONEJIMA, Keiko HISA, Yoshie UCHIBORI
  • Patent number: 9572844
    Abstract: The present invention provides Leuconostoc mesenteroides NTM048 strain deposited under accession No. NITE BP-1519, or a mutant strain thereof or a processed bacterium thereof, and a lactobacillus preparation and an immunity (particularly intestinal immunity) stimulant, containing the lactobacillus or a processed bacterium thereof.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: February 21, 2017
    Assignee: Nitto Pharmaceutical Industries, Ltd.
    Inventors: Kenji Yamamoto, Chiaki Matsuzaki, Keiko Hisa
  • Publication number: 20160229925
    Abstract: Provided are exopolysaccharide produced by novel lactic acid bacteria having an IgA production promoting ability, a production method of the exopolysaccharide, a composition containing the exopolysaccharide, and the like.
    Type: Application
    Filed: September 18, 2014
    Publication date: August 11, 2016
    Applicant: NITTO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Kenji YAMAMOTO, Chiaki MATSUZAKI, Keiko HISA
  • Publication number: 20150374762
    Abstract: The present invention provides Leuconostoc mesenteroides NTM048 strain deposited under accession No. NITE BP-1519, or a mutant strain thereof or a processed bacterium thereof, and a lactobacillus preparation and an immunity (particularly intestinal immunity) stimulant, containing the lactobacillus or a processed bacterium thereof.
    Type: Application
    Filed: February 21, 2014
    Publication date: December 31, 2015
    Applicant: NITTO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Kenji YAMAMOTO, Chiaki MATSUZAKI, Keiko HISA